220 related articles for article (PubMed ID: 26097760)
1. Effects of Prestorage Leukoreduction on the Rate of Febrile Nonhemolytic Transfusion Reactions to Red Blood Cells in a Tertiary Care Hospital.
Rajesh K; Harsh S; Amarjit K
Ann Med Health Sci Res; 2015; 5(3):185-8. PubMed ID: 26097760
[TBL] [Abstract][Full Text] [Related]
2. Universal leukoreduction decreases the incidence of febrile nonhemolytic transfusion reactions to RBCs.
King KE; Shirey RS; Thoman SK; Bensen-Kennedy D; Tanz WS; Ness PM
Transfusion; 2004 Jan; 44(1):25-9. PubMed ID: 14692963
[TBL] [Abstract][Full Text] [Related]
3. The effect of prestorage WBC reduction on the rates of febrile nonhemolytic transfusion reactions to platelet concentrates and RBC.
Yazer MH; Podlosky L; Clarke G; Nahirniak SM
Transfusion; 2004 Jan; 44(1):10-5. PubMed ID: 14692961
[TBL] [Abstract][Full Text] [Related]
4. Prestorage universal WBC reduction of RBC units does not affect the incidence of transfusion reactions.
Uhlmann EJ; Isgriggs E; Wallhermfechtel M; Goodnough LT
Transfusion; 2001 Aug; 41(8):997-1000. PubMed ID: 11493730
[TBL] [Abstract][Full Text] [Related]
5. Characterization of reactions after transfusion of cellular blood components that are white cell reduced before storage.
Federowicz I; Barrett BB; Andersen JW; Urashima M; Popovsky MA; Anderson KC
Transfusion; 1996 Jan; 36(1):21-8. PubMed ID: 8607149
[TBL] [Abstract][Full Text] [Related]
6. Transfusion-associated adverse reactions (TAARs) and cytokine accumulations in the stored blood components: the impact of prestorage versus poststorage leukoreduction.
Chang CC; Lee TC; Su MJ; Lin HC; Cheng FY; Chen YT; Yen TH; Chu FY
Oncotarget; 2018 Jan; 9(4):4385-4394. PubMed ID: 29435110
[TBL] [Abstract][Full Text] [Related]
7. Reduction of febrile but not allergic reactions to RBCs and platelets after conversion to universal prestorage leukoreduction.
Paglino JC; Pomper GJ; Fisch GS; Champion MH; Snyder EL
Transfusion; 2004 Jan; 44(1):16-24. PubMed ID: 14692962
[TBL] [Abstract][Full Text] [Related]
8. Impact of buffy coat reduction on the severity of febrile nonhemolytic transfusion reactions with red cell components.
Singh L; Prinja N; Jain A; Sharma RR; Marwaha N
Asian J Transfus Sci; 2023; 17(1):69-73. PubMed ID: 37188007
[TBL] [Abstract][Full Text] [Related]
9. Effects of prestorage vs poststorage leukoreduction on the rate of febrile nonhemolytic transfusion reactions to platelets.
Wang RR; Triulzi DJ; Qu L
Am J Clin Pathol; 2012 Aug; 138(2):255-9. PubMed ID: 22904138
[TBL] [Abstract][Full Text] [Related]
10. Feeling the burn: the significant burden of febrile nonhemolytic transfusion reactions.
Cohen R; Escorcia A; Tasmin F; Lima A; Lin Y; Lieberman L; Pendergrast J; Callum J; Cserti-Gazdewich C
Transfusion; 2017 Jul; 57(7):1674-1683. PubMed ID: 28369916
[TBL] [Abstract][Full Text] [Related]
11. Characterization of reactions after exclusive transfusion of white cell-reduced cellular blood components.
Dzieczkowski JS; Barrett BB; Nester D; Campbell M; Cook J; Sugrue M; Andersen JW; Anderson KC
Transfusion; 1995 Jan; 35(1):20-5. PubMed ID: 7998063
[TBL] [Abstract][Full Text] [Related]
12. The influence of leukoreduction on the acute transfusion-related complication rate in 455 dogs receiving 730 packed RBCs: 2014-2017.
Davidow EB; Montgomery H; Mensing M
J Vet Emerg Crit Care (San Antonio); 2022 Jul; 32(4):479-490. PubMed ID: 35043550
[TBL] [Abstract][Full Text] [Related]
13. Randomized double-blinded clinical trial on acute transfusion reactions in dogs receiving leukoreduced versus nonleukoreduced packed red blood cells.
Radulescu SM; Skulberg R; McDonald C; Chan DL; Humm K
J Vet Intern Med; 2021 May; 35(3):1325-1332. PubMed ID: 33960540
[TBL] [Abstract][Full Text] [Related]
14. Decrease in the Risk of Posttransplant Hepatocellular Carcinoma Recurrence After the Conversion to Prestorage Leukoreduction for Transfused Red Blood Cells.
Kwon JH; Han S; Jang JS; Lee KW; Ahn JH; Kim K; Jeon S; Gwak MS; Ko JS; Kim GS; Joh JW; Cho D
Transplantation; 2021 Mar; 105(3):577-585. PubMed ID: 32265418
[TBL] [Abstract][Full Text] [Related]
15. Hypothermic storage of leukoreduced red blood cells for greater than 21 days is a safe alternative to irradiation.
Mykhailova O; Turner TR; Olafson C; Howell A; Nahirniak SN; Wizniak J; Gerges HYN; Baldwin T; Clarke G; Acker JP
Transfusion; 2021 Apr; 61(4):1247-1257. PubMed ID: 33481275
[TBL] [Abstract][Full Text] [Related]
16. Effects of Leukoreduction and Premedication With Acetaminophen and Diphenhydramine in Minimizing Febrile Nonhemolytic Transfusion Reactions and Allergic Transfusion Reactions During and After Blood Product Administration: A Literature Review With Recommendations for Practice.
Duran J; Siddique S; Cleary M
J Pediatr Oncol Nurs; 2014 Jul; 31(4):223-229. PubMed ID: 24794886
[TBL] [Abstract][Full Text] [Related]
17. The use of leukoreduced red blood cell products is associated with fewer infectious complications in trauma patients.
Friese RS; Sperry JL; Phelan HA; Gentilello LM
Am J Surg; 2008 Jul; 196(1):56-61. PubMed ID: 18513694
[TBL] [Abstract][Full Text] [Related]
18. Level of platelet-derived cytokines in leukoreduced red blood cells is influenced by the processing method and type of leukoreduction filter.
Glenister KM; Sparrow RL
Transfusion; 2010 Jan; 50(1):185-9. PubMed ID: 19694993
[TBL] [Abstract][Full Text] [Related]
19. Platelet transfusions in children: results of a randomized, prospective, crossover trial of plasma removal and a prospective audit of WBC reduction.
Couban S; Carruthers J; Andreou P; Klama LN; Barr R; Kelton JG; Heddle NM
Transfusion; 2002 Jun; 42(6):753-8. PubMed ID: 12147029
[TBL] [Abstract][Full Text] [Related]
20. Analysis of clinical presentations of allergic transfusion reactions and febrile non-haemolytic transfusion reactions in paediatric patients.
Yanagisawa R; Tatsuzawa Y; Ono T; Kobayashi J; Tokutake Y; Hidaka E; Sakashita K; Nakamura T
Vox Sang; 2019 Nov; 114(8):826-834. PubMed ID: 31463954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
